🇦🇺 Australia Country × Condition
hepatocellular carcinoma Clinical Trials in Australia
Active clinical trials for hepatocellular carcinoma with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 3, Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT07836530 Phase 3
Recruiting
Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular Carcinoma
Enrollment
492 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → NCT06084481 Phase 1
Recruiting
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Enrollment
325 pts
Country
🇦🇺 Australia
AbbVie
View Trial → NCT06478693 Phase 1
Recruiting
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Enrollment
70 pts
Country
🇦🇺 Australia
Myeloid Therapeutics
View Trial → Frequently Asked Questions
How many hepatocellular carcinoma clinical trials are active in Australia?
There are currently 3 active clinical trials for hepatocellular carcinoma with sites in Australia, of which 3 are actively recruiting patients.
How can I join a hepatocellular carcinoma clinical trial in Australia?
To join a hepatocellular carcinoma clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hepatocellular carcinoma trials in Australia?
Active hepatocellular carcinoma trials in Australia span Phase 3, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology